Crispr Therapeutics Ag (CRSP)

Total Costs & Expenses

$545.26M

TTM · Period ending: · USD

CRSP logo

CRSP Total Costs & Expenses

Latest reported$545.26M
CRSP TTM Total Costs & Expenses ($26.02M → $545.26M)
High-resolution chart · PNG

CRSP total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
545,258,999
554,244,999
571,828,000
515,788,000
493,572,000
511,386,000
503,188,000
534,017,000
555,696,000
569,142,000
592,538,000
593,668,000
643,739,000
661,934,000
673,597,000
700,647,000
647,343,000
601,509,000
540,104,000
489,638,000
453,007,000
396,156,000
355,154,000
313,056,000
293,274,000
267,842,000
242,850,000
222,160,000
199,390,000
182,463,000
162,067,000
148,077,000
124,039,000
110,553,000
105,645,000
101,946,000
92,148,000
84,613,000
73,294,000
58,053,000
48,096,000
34,339,000
26,018,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.